Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

Gene expression profiling predicts clinical outcome of breast cancer.

Nature

Prognosis, Adult, Predictive Value of Tests, Patient Selection, Oligonucleotide Array Sequence Analysis, Lymphatic Metastasis, Humans, Genes, BRCA2, Genes, BRCA1, Gene Expression Profiling, Female, DNA, Neoplasm, Cluster Analysis, Chemotherapy, Adjuvant, therapy, physiopathology, genetics, Breast Neoplasms, Treatment Outcome

Read this article at

ScienceOpenPublisherPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      Breast cancer patients with the same stage of disease can have markedly different treatment responses and overall outcome. The strongest predictors for metastases (for example, lymph node status and histological grade) fail to classify accurately breast tumours according to their clinical behaviour. Chemotherapy or hormonal therapy reduces the risk of distant metastases by approximately one-third; however, 70-80% of patients receiving this treatment would have survived without it. None of the signatures of breast cancer gene expression reported to date allow for patient-tailored therapy strategies. Here we used DNA microarray analysis on primary breast tumours of 117 young patients, and applied supervised classification to identify a gene expression signature strongly predictive of a short interval to distant metastases ('poor prognosis' signature) in patients without tumour cells in local lymph nodes at diagnosis (lymph node negative). In addition, we established a signature that identifies tumours of BRCA1 carriers. The poor prognosis signature consists of genes regulating cell cycle, invasion, metastasis and angiogenesis. This gene expression profile will outperform all currently used clinical parameters in predicting disease outcome. Our findings provide a strategy to select patients who would benefit from adjuvant therapy.

      Related collections

      Author and article information

      Journal
      10.1038/415530a
      11823860

      Comments

      Comment on this article